Barriers to hormone therapy following prophylactic bilateral salpingo-oophorectomy in BRCA1/2 mutation carriers.

Jessica B DiSilvestro,Jessica Haddad,Katina Robison,Lindsey Beffa,Jessica Laprise,Jennifer Scalia-Wilbur,Christina Raker,Melissa Clark,Elizabeth Lokich,Erin Hofstatter,Disha Dalela,Amy Brown,Leslie Bradford,Maris Toland,Ashley Stuckey

Menopause (New York, N.Y.)（2023）

引用 0|浏览8

暂无评分

摘要

BRCA mutation carriers frequently undergo prophylactic BSO at young ages, and less than half report using HT. This study highlights barriers to HT use, such as patient fears and physician discouragement, and identifies potential areas to improve educational efforts.

查看译文

关键词

BRCA, Hormone therapy, Physician counseling, Risk reducing

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要